Azithromycin Treatment for the Airway Microbiome in Asthma
common.study.values.description
“Azithromycin Treatment for the Airway Microbiome in Asthma”
The purpose of this study to determine whether the bacteria inside the lungs of people with asthma can be modified (changed) if they are given an antibiotic and if this change is associated with an improvement in asthma symptoms.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Azithromycin
8 weeks of Azithromycin (250 mg) once daily by mouth
Drug - Placebo
Placebo
participant.views.study.view.additional
participant.views.study.view.scientific-title
The AZITRAMBA Trial: Azithromycin Treatment for the Airway Microbiome in Asthma
common.study.values.clinical-trial-id
NCT03736629
participant.views.study.view.id
azpB8d
